Which clinical markers for appropriate timing of surfactant therapy?

Which clinical markers for appropriate timing of surfactant therapy?

Authors

  • G. Lista
  • F. Castoldi

Keywords:

Surfactant, clinical markers, neonate

Abstract

Preterm infants with RDS need adequate resuscitation maneuvers and appropriate timing of surfactant replacement but about the latter there is not an universal consensus. A correct evaluation should consider at the same time the administration of antenatal steroids, the radiological criteria, the clinical presentation, the FiO2 level, OI and a/ApO2.

Downloads

Published

01-06-2013

Issue

Vol. 84 No. 1 (2013): Supplement

Section

Focus on

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

1.
Lista G, Castoldi F. Which clinical markers for appropriate timing of surfactant therapy?. Acta Biomed. 2013;84(1):15-17. Accessed February 23, 2025. https://mattioli1885journals.com/index.php/actabiomedica/article/view/2938